Strata Critical Medical Statistics
Total Valuation
SRTA has a market cap or net worth of $533.45 million. The enterprise value is $514.96 million.
| Market Cap | 533.45M |
| Enterprise Value | 514.96M |
Important Dates
The last earnings date was Tuesday, August 4, 2026, before market open.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SRTA has 88.47 million shares outstanding. The number of shares has increased by 6.59% in one year.
| Current Share Class | 88.47M |
| Shares Outstanding | 88.47M |
| Shares Change (YoY) | +6.59% |
| Shares Change (QoQ) | -4.39% |
| Owned by Insiders (%) | 14.06% |
| Owned by Institutions (%) | 50.82% |
| Float | 62.89M |
Valuation Ratios
The trailing PE ratio is 12.79 and the forward PE ratio is 141.88.
| PE Ratio | 12.79 |
| Forward PE | 141.88 |
| PS Ratio | 2.09 |
| Forward PS | 1.70 |
| PB Ratio | 1.88 |
| P/TBV Ratio | 4.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 12.84 |
| EV / Sales | 2.02 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.64, with a Debt / Equity ratio of 0.02.
| Current Ratio | 2.64 |
| Quick Ratio | 1.45 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -9.22% and return on invested capital (ROIC) is -2.14%.
| Return on Equity (ROE) | -9.22% |
| Return on Assets (ROA) | -1.86% |
| Return on Invested Capital (ROIC) | -2.14% |
| Return on Capital Employed (ROCE) | -7.11% |
| Weighted Average Cost of Capital (WACC) | 16.47% |
| Revenue Per Employee | $782,798 |
| Profits Per Employee | $123,000 |
| Employee Count | 327 |
| Asset Turnover | 0.87 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +53.05% in the last 52 weeks. The beta is 2.24, so SRTA's price volatility has been higher than the market average.
| Beta (5Y) | 2.24 |
| 52-Week Price Change | +53.05% |
| 50-Day Moving Average | 5.47 |
| 200-Day Moving Average | 5.01 |
| Relative Strength Index (RSI) | 65.03 |
| Average Volume (20 Days) | 1,168,056 |
Short Selling Information
The latest short interest is 4.33 million, so 4.89% of the outstanding shares have been sold short.
| Short Interest | 4.33M |
| Short Previous Month | 4.08M |
| Short % of Shares Out | 4.89% |
| Short % of Float | 6.88% |
| Short Ratio (days to cover) | 3.22 |
Income Statement
In the last 12 months, SRTA had revenue of $255.98 million and earned $40.22 million in profits. Earnings per share was $0.47.
| Revenue | 255.98M |
| Gross Profit | 54.40M |
| Operating Income | -8.81M |
| Pretax Income | -23.16M |
| Net Income | 40.22M |
| EBITDA | -4.12M |
| EBIT | -20.41M |
| Earnings Per Share (EPS) | $0.47 |
Balance Sheet
The company has $22.75 million in cash and $4.26 million in debt, with a net cash position of $18.50 million or $0.21 per share.
| Cash & Cash Equivalents | 22.75M |
| Total Debt | 4.26M |
| Net Cash | 18.50M |
| Net Cash Per Share | $0.21 |
| Equity (Book Value) | 279.32M |
| Book Value Per Share | 3.16 |
| Working Capital | 75.23M |
Cash Flow
In the last 12 months, operating cash flow was -$36.03 million and capital expenditures -$12.42 million, giving a free cash flow of -$48.45 million.
| Operating Cash Flow | -36.03M |
| Capital Expenditures | -12.42M |
| Depreciation & Amortization | 16.03M |
| Net Borrowing | n/a |
| Free Cash Flow | -48.45M |
| FCF Per Share | -$0.55 |
Margins
Gross margin is 21.25%, with operating and profit margins of -3.44% and 15.71%.
| Gross Margin | 21.25% |
| Operating Margin | -3.44% |
| Pretax Margin | -9.05% |
| Profit Margin | 15.71% |
| EBITDA Margin | -1.61% |
| EBIT Margin | -7.97% |
| FCF Margin | n/a |
Dividends & Yields
SRTA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.59% |
| Shareholder Yield | -6.59% |
| Earnings Yield | 7.52% |
| FCF Yield | -9.06% |
Analyst Forecast
The average price target for SRTA is $9.56, which is 58.54% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $9.56 |
| Price Target Difference | 58.54% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 17.28% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SRTA has an Altman Z-Score of 4.94 and a Piotroski F-Score of 3.
| Altman Z-Score | 4.94 |
| Piotroski F-Score | 3 |